Publication Name	World Journal of Gastroenterology
Manuscript ID	119898
Country	Mexico

Category	Gastroenterology & Hepatology
Manuscript Type	Evidence Review
Article Title	Interplay between cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease: Clinical evidence on cardiovascular disease
Manuscript Source	Invited Manuscript
All Author List	Jorge Gutiérrez-Cuevas, Ana Sandoval-Rodriguez, Jesús Garcia-Bañuelos, Marcelo Heron Petri and Juan Armendariz-Borunda
Funding Agency and Grant Number	Funding Agency Grant Number Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Mexico No. CF-2023-I-473
Corresponding Author	Jorge Gutiérrez-Cuevas, PhD, Professor, Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, 950 Sierra Mojada Street, Guadalajara 44340, Jalisco, Mexico. gutierrezcj05@gmail.com
Key Words	Metabolic dysfunction-associated steatotic liver disease; Diagnostic criteria; Cardiometabolic comorbidities; Insulin resistance; Systemic inflammation; Oxidative stress; Endothelial dysfunction; Cardiovascular disease; Therapeutic strategies
Core Tip	Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic liver disease, mostly prevalent in Latin America, associated with the development of cardiovascular disease (CVD). Its management and treatment can be challenging, especially in advanced stages (fibrosis and cirrhosis); thus, this disease should be treated by a multidisciplinary team of hepatologists, cardiologists, and nutritionists (among others) in order to reduce liver-related and cardiovascular risk factors. This comprehensive review provides insight into the clinical evidence of the connection between MASLD and CVD through cardiometabolic risk factors.
Citation	Gutiérrez-Cuevas J, Sandoval-Rodriguez A, Garcia-Bañuelos J, Petri MH, Armendariz-Borunda J. Interplay between cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease: Clinical evidence on cardiovascular disease. World J Gastroenterol 2026; In press

Received	2026-02-10 01:58
Peer-Review Started	2026-02-10 01:58
First Decision by Editorial Office Director	2026-03-20 10:54
Return for Revision	2026-03-20 10:54
Revised	2026-04-11 04:48
Publication Fee Transferred
Second Decision by Editor	2026-05-18 02:48
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-05-18 08:52
Articles in Press	2026-05-18 08:52
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright	©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com